CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 46 filers reported holding CASI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,067,000 | +9.1% | 1,320,155 | +7.9% | 0.14% | -4.1% |
| Q4 2021 | $978,000 | -32.8% | 1,223,067 | 0.0% | 0.15% | +41.7% |
| Q3 2021 | $1,456,000 | -25.9% | 1,223,067 | -3.6% | 0.10% | -35.2% |
| Q2 2021 | $1,966,000 | -35.4% | 1,268,154 | 0.0% | 0.16% | +55.9% |
| Q1 2021 | $3,044,000 | -18.6% | 1,268,154 | 0.0% | 0.10% | -38.2% |
| Q4 2020 | $3,741,000 | +58.8% | 1,268,154 | -17.6% | 0.16% | -3.5% |
| Q3 2020 | $2,356,000 | -9.4% | 1,539,910 | +48.1% | 0.17% | -17.4% |
| Q2 2020 | $2,600,000 | +22.6% | 1,039,910 | 0.0% | 0.21% | +29.4% |
| Q1 2020 | $2,121,000 | – | 1,039,910 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |